The Intersection of DNA Damage Response and Ferroptosis-A Rationale for Combination Therapeutics

被引:27
|
作者
Chen, Po-Han [1 ,2 ,3 ]
Tseng, Watson Hua-Sheng [1 ,2 ,4 ]
Chi, Jen-Tsan [1 ,2 ]
机构
[1] Duke Univ, Sch Med, Dept Mol Genet & Microbiol, Durham, NC 27710 USA
[2] Duke Univ, Sch Med, Ctr Genom & Computat Biol, Durham, NC 27710 USA
[3] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA
[4] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan
来源
BIOLOGY-BASEL | 2020年 / 9卷 / 08期
关键词
ferroptosis; DNA damage; ATM; ATR; p53; MDM2; MDMX; CELL-DEATH; ATM ACTIVATION; P53; ACTIVATION; ATAXIA-TELANGIECTASIA; ONCOPROTEIN MDM2; HIPPO PATHWAY; PROTEIN; PHOSPHORYLATION; PROMOTES; METABOLISM;
D O I
10.3390/biology9080187
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Ferroptosis is a novel form of iron-dependent cell death characterized by lipid peroxidation. While the importance and disease relevance of ferroptosis are gaining recognition, much remains unknown about its interaction with other biological processes and pathways. Recently, several studies have identified intricate and complicated interplay between ferroptosis, ionizing radiation (IR), ATM (ataxia-telangiectasia mutated)/ATR (ATM and Rad3-related), and tumor suppressor p53, which signifies the participation of the DNA damage response (DDR) in iron-related cell death. DDR is an evolutionarily conserved response triggered by various DNA insults to attenuate proliferation, enable DNA repairs, and dispose of cells with damaged DNA to maintain genome integrity. Deficiency in proper DDR in many genetic disorders or tumors also highlights the importance of this pathway. In this review, we will focus on the biological crosstalk between DDR and ferroptosis, which is mediated mostly via noncanonical mechanisms. For clinical applications, we also discuss the potential of combining ionizing radiation and ferroptosis-inducers for synergistic effects. At last, various ATM/ATR inhibitors under clinical development may protect ferroptosis and treat many ferroptosis-related diseases to prevent cell death, delay disease progression, and improve clinical outcomes.
引用
收藏
页码:1 / 15
页数:15
相关论文
共 50 条
  • [31] Targeting mechanisms of the DNA damage response (DDR) to overcome acquired resistance to conventional anticancer therapeutics (CATs)
    Mann, J.
    Fritz, G.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2021, 394 (SUPPL 1) : S30 - S31
  • [32] Ferroptosis suppressed the growth of melanoma that may be related to DNA damage
    Wang, Zhenying
    Jin, Dehui
    Ma, Dongmei
    Ji, Cancan
    Wu, Wangli
    Xu, Linlin
    Zhang, Li
    DERMATOLOGIC THERAPY, 2019, 32 (04)
  • [33] Ethanol Induces ATM-mediated DNA Damage Response along with Additional Oxidative DNA Damage and Mitochondrial Injury that is Amenable to Receptor-mediated Therapeutics
    Sharma, Yogeshwar
    Gupta, Sanjeev
    HEPATOLOGY, 2017, 66 : 707A - 708A
  • [34] Signaling dynamics of DNA damage response invoked by combination therapy are dose-dependent
    Koh, Siang-Boon
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2019, 294 (06) : 2191 - 2191
  • [35] DNA Damage and DNA Damage Response in Chronic Myeloid Leukemia
    Popp, Henning D.
    Kohl, Vanessa
    Naumann, Nicole
    Flach, Johanna
    Brendel, Susanne
    Kleiner, Helga
    Weiss, Christel
    Seifarth, Wolfgang
    Saussele, Susanne
    Hofmann, Wolf-Karsten
    Fabarius, Alice
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (04)
  • [36] DNA DAMAGE RESPONSE A ligase makes sense of DNA damage
    Wrighton, Katharine H.
    NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2014, 15 (02) : 76 - 76
  • [37] Caffeine and DNA Damage Response: The Effect of Caffeine on DNA Damage Response Genes in Zebrafish
    Cox, A.
    Joseph, K.
    Gestl, E. E.
    MOLECULAR BIOLOGY OF THE CELL, 2015, 26
  • [38] Mechanistic Rationale to Target PTEN-Deficient Tumor Cells with Inhibitors of the DNA Damage Response Kinase ATM
    McCabe, Nuala
    Hanna, Conor
    Walker, Steven M.
    Gonda, David
    Li, Jie
    Wikstrom, Katarina
    Savage, Kienan I.
    Butterworth, Karl T.
    Chen, Clark
    Harkin, D. Paul
    Prise, Kevin M.
    Kennedy, Richard D.
    CANCER RESEARCH, 2015, 75 (11) : 2159 - 2165
  • [39] Novel therapeutics in combination with radiotherapy to improve cancer treatment: Rationale, mechanisms of action and clinical perspective
    Verheij, Marcel
    Vens, Conchita
    van Triest, Baukelien
    DRUG RESISTANCE UPDATES, 2010, 13 (1-2) : 29 - 43
  • [40] DNA damage response and transcription
    Lagerwerf, Saskia
    Vrouwe, Mischa G.
    Overmeer, Rene M.
    Fousteri, Maria I.
    Mullenders, Leon H. F.
    DNA REPAIR, 2011, 10 (07) : 743 - 750